EXD3: Key Regulator of Gene Expression and Cellular Processes

Target Name: EXD3

NCBI ID: G54932

EXD3

EXD3: Key Regulator of Gene Expression and Cellular Processes

EXD3, also known as Exonuclease 3'-5' domain containing 3, is a protein that is expressed in various tissues and cells in the human body. It is a key regulator of gene expression, and is involved in the process of RNA polymerase II (RNA-II) initiation. EXD3 has also been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

The EXD3 protein is composed of a 3'-5' domain that contains three unique amino acids: alanine, glutamic acid, and aspartic acid. This 3'-5' domain is the region of the protein that is responsible for its unique structure and function.

EXD3 has been shown to play a role in the regulation of gene expression by interacting with specific DNA sequences. This interaction between EXD3 and DNA is critical for the regulation of gene expression, as it allows EXD3 to access and modify the DNA.

EXD3 has also been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. For example, EXD3 has been shown to promote the survival of cancer cells, and to contribute to the development of certain diseases such as neurodegenerative disorders.

In addition to its role in gene expression and cellular processes, EXD3 has also been shown to be a potential drug target. Researchers have identified several potential small molecules that can inhibit the activity of EXD3, and these compounds have been shown to have a range of potential therapeutic benefits.

One of the potential therapeutic benefits of EXD3 is its ability to promote the growth and survival of cancer cells. This makes it an attractive target for cancer therapies that are designed to inhibit cell growth and promote cell death.

Another potential therapeutic benefit of EXD3 is its role in the regulation of cellular processes such as cell apoptosis. EXD3 has been shown to play a role in the regulation of cell apoptosis, and it is possible that it may be a useful target for therapies that are designed to promote or inhibit apoptosis.

In addition to its potential therapeutic benefits, EXD3 is also a valuable biomarker for the study of cellular processes such as gene expression and apoptosis. Researchers have used a variety of techniques to study the behavior of EXD3 in different cellular contexts, and have identified a range of potential applications for this protein in the study of disease.

Overall, EXD3 is a protein that has significant potential as a drug target or biomarker. Further research is needed to fully understand its role in cellular processes and its potential therapeutic benefits.

Protein Name: Exonuclease 3'-5' Domain Containing 3

Functions: Possesses 3'-5' exoribonuclease activity. Required for 3'-end trimming of AGO1-bound miRNAs (By similarity)

The "EXD3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EXD3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets